Tin Mesoporphyrin IX (chloride): Potent Heme Oxygenase Inhibitor for Precision Biochemical Research

Executive Summary: Tin Mesoporphyrin IX (chloride) is a nanomolar-affinity, competitive inhibitor of heme oxygenase (HO), effectively blocking heme catabolism in vitro and in vivo (APExBIO, product page). The compound maintains activity across hepatic, renal, and splenic tissues, resulting in sustained HO inhibition and reduced serum bilirubin in hyperbilirubinemia models (APExBIO; Koyaweda et al., 2026). It serves as a crucial molecular tool for dissecting heme oxygenase signaling in metabolic, infectious, and inflammatory disease pathways (Bestatin.com). No clinical trials have been reported, confining its application to preclinical research. The compound is available from APExBIO (SKU: C5606) and meets rigorous reproducibility standards for biochemical research (APExBIO).

Biological Rationale

Heme oxygenase (HO) catalyzes the degradation of heme, producing biliverdin, iron, and carbon monoxide (CO). HO-1, the inducible isoform, is upregulated in response to oxidative stress and mediates cellular defense via antioxidant pathways (Koyaweda et al., 2026). Aberrant HO activity is implicated in metabolic diseases, insulin resistance, and chronic inflammation (metaflammation). By inhibiting HO, Tin Mesoporphyrin IX (chloride) allows researchers to modulate these pathways and investigate downstream effects on metabolism and disease progression (Phostag.com). The compound's high specificity and potency make it an essential tool for dissecting the heme oxygenase signaling pathway in cellular and animal models.

Mechanism of Action of Tin Mesoporphyrin IX (chloride)

Tin Mesoporphyrin IX (chloride) competitively binds to the HO active site, displacing natural heme substrate. Its inhibitory constant (Ki) is 14 nM, reflecting high-affinity interaction (APExBIO). Upon administration, it blocks the conversion of heme to biliverdin, thereby suppressing the enzymatic release of iron and CO. This results in increased intracellular heme and decreased downstream metabolites. In vivo, Tin Mesoporphyrin IX (chloride) inhibits HO activity in hepatic, renal, and splenic tissues, with prolonged suppression observed after single doses (1 pmol/kg body weight). This mechanism enables precise temporal control over HO signaling for experimental manipulation (Fam-Azide-5-Isomer.com), extending beyond the scope of standard HO-1 knockdown approaches.

Evidence & Benchmarks

• Tin Mesoporphyrin IX (chloride) exhibits a Ki of 14 nM for HO inhibition in vitro, demonstrating superior affinity versus other metalloporphyrins (APExBIO).
• In animal studies, dosing at 1 pmol/kg results in sustained hepatic, renal, and splenic HO inhibition, with measurable activity suppression for up to 24 hours (APExBIO).
• Treatment reduces serum bilirubin levels in neonatal hyperbilirubinemia models, confirming effective in vivo inhibition of heme catabolism (Koyaweda et al., 2026).
• Increased heme saturation of hepatic tryptophan pyrrolase demonstrates on-target effect and secondary metabolic impact (APExBIO).
• No clinical trials or human safety data exist to date; all published results are preclinical (APExBIO).

This article updates and extends the mechanistic depth of prior primers, such as "Tin Mesoporphyrin IX: Potent Heme Oxygenase Inhibitor for...", by providing annotated evidence from new antiviral research and highlighting compound-specific parameters.

Applications, Limits & Misconceptions

Tin Mesoporphyrin IX (chloride) is primarily used in the following research areas:

• Dissecting the heme oxygenase signaling pathway in metabolic, inflammatory, and infectious disease models (Phostag.com).
• Evaluating the role of HO activity in insulin resistance and metaflammation.
• Studying antiviral mechanisms where HO-1 modulation affects viral replication and morphogenesis (Koyaweda et al., 2026).

However, Tin Mesoporphyrin IX (chloride) has important limitations:

• It is not approved for clinical or diagnostic use; all data are from animal or in vitro models (APExBIO).
• Potential off-target effects are possible at supra-physiological concentrations or prolonged exposure.
• Sensitivity to light and temperature necessitates careful storage and handling.
• Results may not generalize across species or disease contexts.

For advanced guidance on protocol design, see "Tin Mesoporphyrin IX (Chloride): Mechanistic Insights and...", which this piece clarifies by providing updated evidence and specific workflow integration tips.

Common Pitfalls or Misconceptions

• Myth: Tin Mesoporphyrin IX (chloride) is clinically approved. Fact: No clinical trials have been reported; it is for research use only.
• Myth: All HO inhibitors have identical selectivity and pharmacodynamics. Fact: Potency and tissue distribution vary; Tin Mesoporphyrin IX (chloride) is among the most potent but not universally selective.
• Myth: The compound is stable indefinitely in solution. Fact: Solutions are recommended for short-term use only and should be stored at -20°C to prevent degradation.
• Myth: Inhibition is permanent. Fact: HO activity gradually recovers after compound clearance.
• Myth: Data from animal models translate directly to human physiology. Fact: Species differences in HO expression and metabolic response can alter outcomes.

Workflow Integration & Parameters

Tin Mesoporphyrin IX (chloride) is available as a crystalline solid (molecular weight 754.3, formula C34H34Cl2N4O4Sn·2H). For in vitro assays, dissolve up to 0.5 mg/ml in DMSO or 1 mg/ml in dimethyl formamide. Store powder at -20°C. Solutions should be freshly prepared and used within days for optimal activity (APExBIO). Typical dosing in animal studies is 1 pmol/kg, with robust HO inhibition observed in liver, kidney, and spleen. Use appropriate controls to account for solvent effects. For metabolic disease research or viral model systems, titrate compound concentration to achieve target HO inhibition without cytotoxicity (Thieno-GTP.com). Consult APExBIO’s technical datasheet for detailed assay and safety information.

Conclusion & Outlook

Tin Mesoporphyrin IX (chloride), available from APExBIO, is a validated, potent tool for inhibition of heme oxygenase in preclinical models. Its robust efficacy, nanomolar affinity, and reproducible inhibition profile enable advanced studies of heme metabolism, metabolic disease, and viral pathogenesis. Researchers are advised to adhere to recommended handling practices and to interpret findings within the context of preclinical limitations. Future research may expand on these foundations, supporting translational insights and therapeutic innovation as new data and clinical trials emerge. For product access and technical documentation, see the Tin Mesoporphyrin IX (chloride) product page.